BMRN - BioMarin appoints Alexander Hardy as president and chief executive officer
2023-11-01 16:27:34 ET
More on BioMarin Pharmaceutical
- BioMarin: Growth Drivers Remain Intact
- BioMarin: Q2 2023 Confirmed My Bullish View
- BioMarin Pharmaceutical Q3 2023 Earnings Preview
- Bernstein upgrades BioMarin to market perform, citing valuation
- Seeking Alpha’s Quant Rating on BioMarin Pharmaceutical
For further details see:
BioMarin appoints Alexander Hardy as president and chief executive officer